The Doseo technology platform opened its doors on October 1, 2014. All radiotherapy and medical imaging stakeholders—manufacturers, researchers, and clinicians—can use the platform’s advanced technology and experienced staff for their own R&D projects. The platform is open during business hours.
The platform was selected to receive support under the French government’s 2009–2013 cancer plan, was named a French Single Interministerial Fund Innovation Platform in 2010, and is certified by the Medicen Paris Region cluster.
The Doseo platform for research and development in radiotherapy technology was set up to improve radiotherapy technology while minimizing the associated risks.
The center has four missions:
Doseo is backed by the French Alternative Energies and Atomic Energy Commission (CEA) and is located near NeuroSpin in an area of the CEA-Saclay campus that is open to the public.
The center is home to researchers from several institutes, including CEA LIST for R&D; LNE-LNHB for dose metrology; and INSTN (France’s National Institute for Nuclear Science and Technology) for training.
These organizations provide financing for Doseo, of course. But they also deliver international-caliber know-how in research, training, and metrology, and make active contributions to Doseo’s research strategy and programming.
Doseo is a far-reaching, multi-partner initiative that exists thanks to financing from:
CEA SACLAY DOSEO
Point courrier 181
91191 GIF SUR YVETTE CEDEX
€8 million in equipment.
Doseo was founded thanks to financing in part by French national and local governments.